AVR 1.37% $15.09 anteris technologies ltd

News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-124

  1. 12,060 Posts.
    lightbulb Created with Sketch. 156
    very true, what brent says is correct

    funded by one group of holders to give the benefits to a new set (50% straight to SB and SIO so far at a piitance)

    This is a great entry point if the companies intention is to stave off administration and/or not hand over another massive portion of the company to the new owners. If that is their intention then no entry point is good

    Lets see if WP has a believable plan to do this.
    Any effective CR at this point effectively hands over at least another 30-40%

    What are the estimates of capital to see this through to self funding. Look at expenditure, revenue and do the maths.
    Last edited by pauljbo470: 12/03/19
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$15.09
Change
-0.210(1.37%)
Mkt cap ! $318.9M
Open High Low Value Volume
$15.10 $15.38 $15.02 $55.26K 3.65K

Buyers (Bids)

No. Vol. Price($)
1 98 $15.09
 

Sellers (Offers)

Price($) Vol. No.
$15.57 779 1
View Market Depth
Last trade - 16.10pm 20/08/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.